INSPIREMD 1/18 DL-0001 - Asset Resilience Ratio
INSPIREMD 1/18 DL-0001 (II2) has an Asset Resilience Ratio of 65.23% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INSPIREMD 1/18 DL-0001 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how INSPIREMD 1/18 DL-0001's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INSPIREMD 1/18 DL-0001 balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down INSPIREMD 1/18 DL-0001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of INSPIREMD 1/18 DL-0001 for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €45.27 Million | 65.23% |
| Total Liquid Assets | €45.27 Million | 65.23% |
Asset Resilience Insights
- Very High Liquidity: INSPIREMD 1/18 DL-0001 maintains exceptional liquid asset reserves at 65.23% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
INSPIREMD 1/18 DL-0001 Industry Peers by Asset Resilience Ratio
Compare INSPIREMD 1/18 DL-0001's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for INSPIREMD 1/18 DL-0001 (2021–2025)
The table below shows the annual Asset Resilience Ratio data for INSPIREMD 1/18 DL-0001.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 65.23% | €45.27 Million ≈ $52.93 Million |
€69.40 Million ≈ $81.14 Million |
+31.64pp |
| 2024-12-31 | 33.59% | €15.72 Million ≈ $18.38 Million |
€46.81 Million ≈ $54.72 Million |
-28.09pp |
| 2023-12-31 | 61.67% | €29.38 Million ≈ $34.35 Million |
€47.64 Million ≈ $55.70 Million |
+8.25pp |
| 2022-12-31 | 53.43% | €13.17 Million ≈ $15.40 Million |
€24.65 Million ≈ $28.82 Million |
-2.06pp |
| 2021-12-31 | 55.49% | €22.04 Million ≈ $25.76 Million |
€39.71 Million ≈ $46.43 Million |
-- |
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more